Search research articles
Contact Us
Filters
Showing results (301-310 of 425) with videos related to
Page
of 43
Sort By:
Cardiovascular Diabetology
|
January 8, 2021
Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study
Stephen J Nicholls, Gregory G Schwartz, Kevin A Buhr, et al.
Journal of Clinical Lipidology
|
April 9, 2022
Substantially elevated TSH, not traditional clinical subclinical thyroid disorder groupings, are associated with smaller LDL-P mean size: ELSA-Brasil
Carolina Castro Porto Silva Janovsky, Alessandra C Goulart, Giuliano Generoso, et al.
Circulation
|
July 4, 2015
Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B)
Mohamed B Elshazly, Renato Quispe, Erin D Michos, et al.
JAMA
|
March 29, 2020
Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial
Kausik K Ray, Stephen J Nicholls, Kevin A Buhr, et al.
American Heart Journal
|
September 15, 2019
Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial
Kausik K Ray, Stephen J Nicholls, Henry D Ginsberg, et al.
Maturitas
|
November 11, 2019
Changes in lipoprotein subfractions following menopause in the Longitudinal Study of Adult Health (ELSA-Brasil)
Marília I H Fonseca, Bianca de Almeida-Pititto, Isabela M Bensenor, et al.
Journal of the American Heart Association
|
February 5, 2020
High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study
Renato Quispe, Erin D Michos, Seth S Martin, et al.
Atherosclerosis
|
September 25, 2020
Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: The ELSA-Brasil study
Carolina Castro Porto Silva Janovsky, Giuliano Generoso, Alessandra C Goulart, et al.
BMC Medicine
|
June 22, 2021
Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies
Kamal Awad, Maged Mohammed, Mahmoud Mohamed Zaki, et al.
Archives of Medical Science : AMS
|
October 2, 2019
Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7
Renato Quispe, Aditya D Hendrani, Behnoud Baradaran-Noveiry, et al.
Page
of 43
Search research articles
Search
Showing results (301-310 of 425) with videos related to
Sort By:
Page
of 43
Cardiovascular Diabetology
|
January 8, 2021
Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study
Stephen J Nicholls, Gregory G Schwartz, Kevin A Buhr, et al.
Journal of Clinical Lipidology
|
April 9, 2022
Substantially elevated TSH, not traditional clinical subclinical thyroid disorder groupings, are associated with smaller LDL-P mean size: ELSA-Brasil
Carolina Castro Porto Silva Janovsky, Alessandra C Goulart, Giuliano Generoso, et al.
Circulation
|
July 4, 2015
Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B)
Mohamed B Elshazly, Renato Quispe, Erin D Michos, et al.
JAMA
|
March 29, 2020
Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial
Kausik K Ray, Stephen J Nicholls, Kevin A Buhr, et al.
American Heart Journal
|
September 15, 2019
Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial
Kausik K Ray, Stephen J Nicholls, Henry D Ginsberg, et al.
Maturitas
|
November 11, 2019
Changes in lipoprotein subfractions following menopause in the Longitudinal Study of Adult Health (ELSA-Brasil)
Marília I H Fonseca, Bianca de Almeida-Pititto, Isabela M Bensenor, et al.
Journal of the American Heart Association
|
February 5, 2020
High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study
Renato Quispe, Erin D Michos, Seth S Martin, et al.
Atherosclerosis
|
September 25, 2020
Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: The ELSA-Brasil study
Carolina Castro Porto Silva Janovsky, Giuliano Generoso, Alessandra C Goulart, et al.
BMC Medicine
|
June 22, 2021
Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies
Kamal Awad, Maged Mohammed, Mahmoud Mohamed Zaki, et al.
Archives of Medical Science : AMS
|
October 2, 2019
Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7
Renato Quispe, Aditya D Hendrani, Behnoud Baradaran-Noveiry, et al.
Page
of 43